Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats

Digestive Diseases and Sciences

Volumn 47, Issue 12, 2002, Pages 2751-2757

  Gibson, Rachel J ^a   Keefe, Dorothy M K ^a   Thompson, Fiona M ^b   Clarke, Julie M ^c   Goland, Gary J ^b   Cummins, Adrian G ^b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

^c WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

Apoptosis; Chemotherapy; Interleukin 11; Intestinal mucositis

Indexed keywords

INTERLEUKIN 11; METHOTREXATE;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CELL PROLIFERATION; CONTROLLED STUDY; CRYPT CELL; FEMALE; INTESTINE INJURY; INTESTINE VILLUS; MITOSIS; MORPHOMETRICS; MUCOSA INFLAMMATION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOCARCINOMA; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; FEMALE; INTERLEUKIN-11; INTESTINAL MUCOSA; METHOTREXATE; ORGAN SIZE; RATS; RATS, INBRED STRAINS;

EID: 0036907234     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021061306913     Document Type: Article

References (26)

1. Keefe DMK, Cummins AG, Kotasek D, Dale BM, Sage RE: Small intestinal side effects of chemotherapy: A study comparing symptoms, function and morphology. J Gastroenterol Hepatol 11:A121, 1996
2. Keefe DM, Cummins AG, Dale BM, Kotasek D, Robb TA, Sage RE: Effect of high-dose chemotherapy, on intestinal permeability in humans. Clin Sci 92:385-389, 1997
3. Keefe DMK: The Effect of Cytotoxic Chemotherapy on the Mucosa of the Small Intestine. MD thesis. Adelaide; University of Adelaide, 1998
4. Pico J-L, Avila-Garavito A, Naccache P: Mucositis: Its occurrence, consequences, and treatment in the oncology setting. Oncologist 3:446-451, 1998
5. Potten CS: The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice. Cancer Met Rev 11:179-195, 1992
6. Potten CS, Wilson JW, Booth C: Regulation and significance of apoptosis in the stem cells of the gastrointestinal epithelium. Stem Cells 15:82-93, 1997
7. Keefe DMK, Brealey J, Goland GJ, Cummins AG: Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 47(5):632-637, 2000
8. Ijiri K, Potten CS: Response of intestinal cells of differing topographical and hierarchical status to ten cytotoxic drugs and five sources of radiation. Br J Cancer 47:175-185, 1983
9. Ijiri K, Potten CS: Radiation-hypersensitive cells in small intestinal crypts; their relationships to clonogenic cells. Br J Cancer Suppl 7:20-22, 1986
10. Ijiri K, Potten CS: Further studies on the response of intestinal crypt cells of different hierarchical status to eighteen different cytotoxic agents. Br J Cancer 55:113-123, 1984
11. Du XX, Williams DA: Interleukin-11: A multifunctional growth factor derived from the hematopoietic microenvironment. Blood 83(8):2023-2030, 1994
12. Keith Jr JC, Albert A, Sonis ST, Pfeiffer CJ, Schaub RG: IL-11, a pleiotrophic cytokine: Exciting new effects of IL-11 on gastrointestinal mucosal biology. Stem Cells 12(suppl 1):79-90, 1994
13. Orazi A, Cooper RJ, Tong J, Gordon MS, Battiato L, Sledge Jr GW, Kaye JA, Kahsai M, Hoffman R: Effects of recombinant human interleukin-11 (Numega™ rhIL-11 growth factor) on megakaryocytopoiesis in human bone marrow. Exp Hematol 24:1289-1297, 1996
14. Orazi A, Du X, Yang Z, Kashai M, Williams DA: Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab Invest 75(1):33-42, 1996
15. Potten CS: Interleukin-11 protects the clonogenic stem cells in murine small-intestinal crypts from impairment of their reproductive capacity by radiation. Int J Cancer 62:356-361, 1995
16. Potten CS: Protection of the small intestinal clonogenic stem cells from radiation-induced damage by pretreatment with interleukin 11 also increases murine survival time. Stem Cells 14(4):452-459, 1996
17. Cummins AG, LaBrooy JT, Stanley DP, Rowland R, Shearman DJC: A quantitative histological study of enteropathy associated with HIV infection, Gut 31:317-321, 1990
18. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119(3):493-501, 1992
19. Harper JF: Peritz' F test: BASIC programme of a robust multiple comparison test for statistical analysis of all differences among group means. Comput Biol Med 14:437-445, 1994
20. Trier JS: Morphological alterations induced by methotrexate in the mucosa of human proximal intestine. Gastroenterology 42:295-305, 1962
21. Trier JS: Morphological alterations induced by methotrexate in the mucosa of the proximal small intestine: II. serial observations by electron microscopy, Gastroenterology 43:407-424, 1962
22. Booth C, Potten CS: Effects of IL-11 on the growth of intestinal epithelial cells in vitro. Cell Prolif 28:581-594, 1995
23. Pritchard DM, Potten CS, Hickman JA: The relationships between p53-dependent apoptosis, inhibition of proliferation, 5-fluorouracil-induced histopathology in murine intestinal epithelia. Cancer Res 58:5453-5465, 1998
24. Nandurkar HH, Hilton DJ, Nathan P, Willson T, Nicola N, Begley CG: The human IL-11 receptor requires gp130 for signalling: Demonstration by molecular cloning of the receptor. Oncogene 12:585-593, 1996
25. Hilton DJ, Hilton AA, Raicevic A, Rakar S, Harrison-Smith M, Gough NM, Begley CG, Metcalf D, Nicola NA, Willson TA: Cloning of a murine IL-11 receptor α-chain; requirement for gp130 for high affinity binding and signal transduction. EMBO J 13(20):4765-4775, 1994
26. Perez Castro C, Carbia Nagashima A, Paez Pereda M, Goldberg V, Chervin A, Carrizo G, Molina H, Renner U, Stalla GK, Arzt E: Effects of the gp130 cytokines ciliary neurotropic factor (CNTF) and interleukin-11 on pituitary cells: CNTF receptors on human pituitary adenomas and stimulation of prolactin and GH secretion in normal rat anterior pituituary aggregate cultures. J Endocrinol 169:539-547, 2001